Similar articles

• Management of fetal and neonatal alloimmune thrombocytopenia.

  Kaplan C, Daffos F, Forestier F, Morel-Kopp MC, Tchernia G. Kaplan C, et al. Vox Sang. 1994;67 Suppl 3:85-8. doi: 10.1111/j.1423-0410.1994.tb04550.x. Vox Sang. 1994. PMID: 7975518 Review. No abstract available.
• Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy.

  Kaplan C, Morel-Kopp MC, Clemenceau S, Daffos F, Forestier F, Tchernia G. Kaplan C, et al. Transfus Med. 1992 Dec;2(4):265-71. doi: 10.1111/j.1365-3148.1992.tb00168.x. Transfus Med. 1992. PMID: 1339580 Review.
• Neonatal alloimmune thrombocytopenia.

  Murphy MF, Manley R, Roberts D. Murphy MF, et al. Haematologica. 1999 Jun;84 Suppl EHA-4:110-4. Haematologica. 1999. PMID: 10907486 Review. No abstract available.
• Antenatal management of fetal alloimmune and autoimmune thrombocytopenia.

  Bussel JB, McFarland JG, Berkowitz RL. Bussel JB, et al. Transfus Med Rev. 1990 Apr;4(2):149-62. doi: 10.1016/s0887-7963(90)70260-x. Transfus Med Rev. 1990. PMID: 2134623 Review. No abstract available.
• Antenatal screening of unselected pregnant women for HPA-1a antigen, antibody and alloimmune thrombocytopenia.

  Maslanka K, Guz K, Zupanska B. Maslanka K, et al. Vox Sang. 2003 Nov;85(4):326-7. doi: 10.1111/j.0042-9007.2003.00363.x. Vox Sang. 2003. PMID: 14633260 No abstract available.